处方模式的dupilumab对于成人亚托皮炎:回顾性,观察性队列研究
Torunn E Sivesind1, Ani Oganesyan2, Grace Bosma3
1Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, United States.
JMIR dermatology
|August 30, 2023
概括
黑人患者和那些患有亚托邦神经皮肤炎的人更有可能接受用于治疗亚托邦皮肤炎 (AD) 的dupilumab. 这项研究分析了阿尔茨海默氏症成年人的杜皮卢马布处方模式,揭示了治疗的差异.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托皮炎 (AD) 是一种流行的2型T细胞介导的炎症性皮肤疾病.
- 中度至重度的AD影响大约20%的患者,dupilumab是针对IL-4和IL-13的关键治疗方法.
- 目前FDA批准的治疗方法包括软化剂,局部类固醇和氨酸抑制剂.
研究的目的:
- 在一个大型卫生系统中,对成人亚托皮性皮肤炎患者的杜皮卢马布处方模式进行描述.
- 为了确定与阿托皮性皮肤炎的杜皮卢马布处方相关的患者特征.
主要方法:
- 一项追溯观察队列研究利用来自大学附属卫生系统的电子健康数据.
- 该研究分析了2013年3月至2021年3月的数据,重点关注6421名被诊断患有亚托邦性皮肤炎的成年患者.
- 统变逻辑回归评估了患者特征和杜皮卢马布处方之间的关联.
主要成果:
- 在人口中,阿托皮性皮肤炎 (AD) 的患病率为5.6%.
- 与白人患者相比,患有AD的黑人患者接受dupilumab的可能性是白人患者的两倍多 (OR 2.352).
- 与其他AD变体相比,被诊断患有亚托皮性神经皮炎的患者接受dupilumab的可能性几乎是其两倍 (OR 1.87).
结论:
- 患者的种族和特定的亚托皮性皮炎诊断与dupilumab处方模式的变化有关.
- 这些发现凸显了对亚托皮性皮肤炎的生物治疗处方的潜在差异.
- 需要进一步的研究来理解和解决这些观察到的处方差异.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
353
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
353
Drugs Used in Lower Respiratory Disorders: Overview
487
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
487
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


